• Aldinucci, D., Poletto, D., Zagonel, V., Rupolo, M., Degan, M., Nanni, P., Gattei, V. & Pinto, A. (2000) In vitro and in vivo effects of 2′-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+ T-cell malignancies. British Journal of Haematology, 110, 188196.DOI: 10.1046/j.1365-2141.2000.02129.x
  • Farcet, J.P., Gaulard, P., Marolleau, J.P., Le Couedic, J.P., Henni, T., Gourdin, M.F., Divine, M., Haioun, C., Zafrani, S., Goussens, M., Hercend, T. & Reyes, F. (1990) Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood, 75, 22132219.
  • Kurzrock, R. (2000) Pentostatin (Nipent) in T-cell lymphomas. Seminars in Oncology, 27, 6466.
  • Weidmann, E. (2000) Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia, 14, 991997.
  • Wong, K.F., Chan, J.K., Matutes, E., McCarthy, K., Ng, C.S., Chan, C.H. & Ma, S.K. (1995) Hepatosplenic gamma delta T-cell lymphoma. American Journal of Surgical Pathology, 19, 718726.